1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow 40 mg CBL-514: new trials by email Literature Review of 40 mg CBL-514 trials Research Report on 40 mg CBL-514
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1) 40 mg CBL-514, 60 mg CBL-514, 80 mg CBL-514 - Cellulite | Phase 2 | Completed | Caliway Biopharmaceuticals Co., Ltd. | 12 | 2023-01-09 | 2026-10-21 |
Cellulite (1)
Caliway Biopharmaceuticals Co., Ltd. (1)
United States (1)
Anne Sheu (1)